Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ZEPATIER
- Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole Tablet
- ATTIC - Access To Treat in the Community
- A Prospective Cohort Study to Improve HCV Care in Dialysis Patients
- Transplanting Hepatitis C Lungs Into Negative Lung Recipients
- Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation
- Eight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4
- EBR/GZR for HCV-1b Patients Receiving Hemodialysis
- Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
- A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV Study
- Impact of Hepatitis C Therapy and Bone Health
- 8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis
- Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)
- A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A
- Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant
- Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care
- Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant
- Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
- Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs
- Pembrolizumab With or Without Elbasvir/Grazoprevir and Ribavirin in Treating Patients With Advanced Refractory Liver Cancer
- HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant
- The Dublin Zepatier Study
- Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4
- Study of Oral Treatments for Hepatitis C
- Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients
- Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients
Clinical trials list
click for details